MedPath

DP-13

Generic Name
DP-13

DP13 SAD & MAD in Healthy Male Subjects

Phase 1
Completed
Conditions
Safety and Tolerability
Interventions
Drug: placebo
First Posted Date
2017-02-08
Last Posted Date
2018-04-17
Lead Sponsor
Damian Pharma AG
Target Recruit Count
48
Registration Number
NCT03046589
Locations
🇬🇧

Covance Clinical Research Unit Ltd, Leeds, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath